The Cigna Group (NYSE:CI) Price Target Lowered to $390.00 at UBS Group

The Cigna Group (NYSE:CI) had its target price reduced by UBS Group from $410.00 to $390.00 in a report released on Monday morning,Benzinga reports. UBS Group currently has a buy rating on the health services provider’s stock.

A number of other equities analysts have also weighed in on the stock. Raymond James restated a “strong-buy” rating and issued a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a report on Friday. Stephens lowered their price target on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday. StockNews.com downgraded The Cigna Group from a “buy” rating to a “hold” rating in a report on Friday. Royal Bank of Canada lowered their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, Truist Financial reduced their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, The Cigna Group has a consensus rating of “Buy” and a consensus target price of $378.00.

The Cigna Group Trading Down 0.6 %

Shares of NYSE CI opened at $292.56 on Monday. The firm has a 50-day moving average of $294.40 and a 200 day moving average of $324.18. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The stock has a market cap of $81.38 billion, a P/E ratio of 23.90, a price-to-earnings-growth ratio of 0.97 and a beta of 0.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the prior year, the firm posted $6.79 earnings per share. As a group, sell-side analysts expect that The Cigna Group will post 29.66 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a $1.51 dividend. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.06%. The Cigna Group’s dividend payout ratio (DPR) is presently 45.75%.

Institutional Investors Weigh In On The Cigna Group

Several hedge funds have recently made changes to their positions in CI. Ulland Investment Advisors LLC lifted its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group during the 3rd quarter valued at approximately $37,000. Collier Financial bought a new position in The Cigna Group during the fourth quarter worth $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group in the fourth quarter worth $34,000. Finally, Harbor Capital Advisors Inc. acquired a new stake in The Cigna Group during the third quarter worth about $45,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.